<main role="main" class="detailed-guide" lang="en">
      
<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
    <span class="govuk-caption-xl gem-c-title__context">
      Guidance
    </span>
  <h1 class="gem-c-title__text gem-c-title__text--long">
    Marketing Authorisation Application submission dates for 150-days national and European Commission decision reliance procedures
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">Submission dates and how the submissions using the EC decision reliance procedure work.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
        <div class="app-c-publisher-metadata" lang="en">
    <div class="app-c-published-dates " lang="en">
    Published 1 February 2021
</div>

      <div class="app-c-publisher-metadata__other">
        <dl data-module="track-click">
            <dt class="app-c-publisher-metadata__term">
              From:
            </dt>
            <dd data-module="gem-toggle" class="app-c-publisher-metadata__definition">
                <span class="app-c-publisher-metadata__definition-sentence">
                  <a href="/government/organisations/medicines-and-healthcare-products-regulatory-agency" class="govuk-link">Medicines and Healthcare products Regulatory Agency</a>
                </span>
            </dd>
        </dl>
      </div>
  </div>

    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>





<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

      <div class="app-c-contents-list-with-body" data-module="sticky-element-container">
      <div class="responsive-bottom-margin">
          <nav data-module="track-click" aria-label="Contents" class="gem-c-contents-list  gem-c-contents-list--no-underline " role="navigation">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-options="{&quot;dimension29&quot;:&quot;Submission dates for 150-days assessment procedure for national marketing authorisation applications containing new active substances.&quot;}" data-track-action="content_item 1" data-track-label="#submission-dates-for-150-days-assessment-procedure-for-national-marketing-authorisation-applications-containing-new-active-substances" data-track-category="contentsClicked" href="#submission-dates-for-150-days-assessment-procedure-for-national-marketing-authorisation-applications-containing-new-active-substances">Submission dates for 150-days assessment procedure for national marketing authorisation applications containing new active substances.</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a data-track-label="#submissions-using-the-ec-decision-reliance-procedure-ecdrp" href="#submissions-using-the-ec-decision-reliance-procedure-ecdrp" data-track-action="content_item 2" data-track-category="contentsClicked" data-track-options="{&quot;dimension29&quot;:&quot;Submissions using the EC decision reliance procedure (ECDRP)&quot;}" class="gem-c-contents-list__link govuk-link ">Submissions using the EC decision reliance procedure (ECDRP)</a>

        </li>
    </ol>
</nav>
      </div>
    
      
<div class="gem-c-print-link govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>

      
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
        <div class="govspeak">
<h2>Submission dates for 150-days assessment procedure for national marketing authorisation applications containing new active substances.</h2>

<p>The MHRA will operate a <a href="https://www.gov.uk/guidance/guidance-on-150-day-assessment-for-national-applications-for-medicines" class="govuk-link">150-day Assessment route</a> for high-quality marketing authorisation applications (MAAs).</p>

<p>For applications containing new active substances, submissions should be received by the following dates in order to align with the meeting dates of the Commission on Human Medicines (CHM).</p>

<p>The Marketing authorisation application dossier should be submitted through the <a class="govuk-link" href="https://www.gov.uk/guidance/registering-to-make-submissions-to-the-mhra-from-1-january-2021">MHRA Submissions portal</a> on or before the deadline as detailed below:</p>

<table>
  <thead>
    <tr>
      <th scope="col">CHM meeting</th>
      <th scope="col">Submission deadline</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>6 and 7 May 2021</td>
      <td>8 February 2021</td>
    </tr>
    <tr>
      <td>27 and 28 May 2021</td>
      <td>1 March 2021</td>
    </tr>
    <tr>
      <td>1 and 2 July 2021</td>
      <td>5 April 2021</td>
    </tr>
    <tr>
      <td>5 and 6 August 2021</td>
      <td>10 May 2021</td>
    </tr>
    <tr>
      <td>2 and 3 September 2021</td>
      <td>7 June 2021</td>
    </tr>
    <tr>
      <td>30 September and 1 October 2021</td>
      <td>5 July 2021</td>
    </tr>
    <tr>
      <td>28 and 29 October 2021</td>
      <td>2 August 2021</td>
    </tr>
    <tr>
      <td>25 and 26 November 2021</td>
      <td>30 August 2021</td>
    </tr>
    <tr>
      <td>16 and 17 December 2021</td>
      <td>20 September 2021</td>
    </tr>
    <tr>
      <td>27 and 28 January 2022</td>
      <td>1 November 2021</td>
    </tr>
  </tbody>
</table>

<h2>Submissions using the EC decision reliance procedure (<abbr title="European Commission decision reliance procedure">ECDRP</abbr>)</h2>

<p>Applicants may seek a Great Britain marketing authorisation that relies on a decision taken by the European Commission in respect of a marketing authorisation for the same product in the centralised procedure. This route â€“ the <a class="govuk-link" href="https://www.gov.uk/guidance/european-commission-ec-decision-reliance-procedure">EC decision reliance procedure</a> (<abbr title="European Commission decision reliance procedure">ECDRP</abbr>) - is available to all authorisations including generics products and variations, approved in the centralised procedure.</p>

<p>For new MA applications, on receipt of the positive <abbr title="Committee for Medicinal Products for Human Use">CHMP</abbr> (Committee for Medicinal Products for Human Use) opinion on day 210, or as soon as possible after this date, the <abbr title="European Commission decision reliance procedure">ECDRP</abbr> MAA should be submitted to the MHRA as a single <a rel="external" href="http://esubmission.ema.europa.eu/ectd/" class="govuk-link">electronic Common Technical Document</a> sequence through MHRA Submissions. The submission should include the entire dossier as reviewed by the <abbr title="Committee for Medicinal Products for Human Use">CHMP</abbr>, including the full responses to <abbr title="Committee for Medicinal Products for Human Use">CHMP</abbr> questions, each iteration of the rapporteur assessment report and updates throughout the procedure</p>

<p>When a valid submission is made within 5 days of <abbr title="Committee for Medicinal Products for Human Use">CHMP</abbr> positive opinion, the date of <abbr title="Committee for Medicinal Products for Human Use">CHMP</abbr> positive opinion will be designated Day 0 of the <abbr title="European Commission decision reliance procedure">ECDRP</abbr>, and the MHRA will aim to determine the Great Britain MA as soon as possible following submission of confirmation of the EC decision.</p>

<p>If the application is submitted more than 5 days after the <abbr title="Committee for Medicinal Products for Human Use">CHMP</abbr> positive opinion, Day 0 of the <abbr title="European Commission decision reliance procedure">ECDRP</abbr> will be the date of MAA validation, and determination may not align with the date of the EC decision.</p>

</div>

</div>

      <div class="responsive-bottom-margin">
        <div lang="en" class="app-c-published-dates ">
    Published 1 February 2021
</div>

      </div>

      <div data-sticky-element="" class="app-c-contents-list-with-body__link-wrapper">
        <div class="app-c-contents-list-with-body__link-container">
          <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg width="13" class="app-c-back-to-top__icon" xmlns="http://www.w3.org/2000/svg" height="17" viewBox="0 0 13 17">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

        </div>
      </div>
  </div>
    
<div class="gem-c-print-link govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button data-module="print-link" class="govuk-link gem-c-print-link__button">Print this page</button>
</div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav data-module="gem-toggle" class="gem-c-related-navigation__nav-section" role="navigation">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul data-module="track-click" class="gem-c-related-navigation__link-list">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--footer" href="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" data-track-category="relatedLinkClicked" data-track-action="1.1 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" data-track-options="{&quot;dimension28&quot;:&quot;1&quot;,&quot;dimension29&quot;:&quot;Marketing authorisations, variations and licensing guidance&quot;}">Marketing authorisations, variations and licensing guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>